Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer.

Diana Roth O'Brien,Lillian Boe,Giacomo Montagna,Boris Mueller,Fumiko Chino, John Cuaron,J Isabelle Choi,Amy Xu,Michael Bernstein,Beryl McCormick,Simon Powell,Atif J Khan,Lior Z Braunstein

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览1

暂无评分

摘要

Among a cohort of patients with HER2+ early-stage breast cancer managed with BCS and PBI, we observed a 2-year LR rate of 3.8%, with no regional or distant recurrences and excellent overall survival. These findings require confirmation with longer follow-up among larger cohorts but appear consistent with the excellent results of contemporary randomized trials of PBI unselected for HER2 status.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要